You are here: Industry Insights > Roche

News List

Roche’s antibody cocktail for COVID-19 may face affordability issues in India: GlobalData expresspharma
May 08, 2021
Following the news that Roche has received emergency use authorization (EUA) for a COVID-19 antibody cocktail casirivimab and imdevimab; Prashant Khadayate, Pharma Analyst at GlobalData offers his view.
Tecentriq approved for first-line metastatic NSCLC pharmatimes
May 07, 2021
Roche’s checkpoint inhibitor Tecentriq has gained a new approval from the European Commission, for the first-line treatment of certain patients with metastatic non-small cell lung cancer (NSCLC), its fourth indication in this cancer type.
Roche’s Enspryng leads latest CHMP recommendations pharmatimes
April 27, 2021
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended eight new medicines for approval in its April meeting.
Roche reports 3% increase in group sales in first quarter of 2021 pharmaceutical-technology
April 23, 2021
Roche has reported a 3% increase in group sales to $16.247bn (CHF14.9bn) in the first quarter of 2021 at constant exchange rates.
New Data for Genentech’s Ocrevus (ocrelizumab) Reinforce Significant Benefit on Slowing Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis americanpharmaceuticalreview
April 21, 2021
Genentech, a member of the Roche Group, announced new Ocrevus® (ocrelizumab) analyses supporting its significant benefit on disease progression in early-stage relapsing-remitting multiple sclerosis (RRMS) and primary progressive MS (PPMS) as well as ...
Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81% worldpharmanews
April 14, 2021
Roche confirmed positive results from the phase III REGN-COV 2069 trial assessing the ability of the investigational antibody cocktail casirivimab and imdevimab to reduce the risk and burden of COVID-19 infection among household contacts of SARS-CoV-2 ...
Thousands to benefit from five-minute breast cancer treatment pharmatimes
April 07, 2021
NHS England is rolling out an injection that dramatically cuts the amount of time breast cancer patients spend in hospital from two and a half hours to as little as five minutes across the country, following a deal with its manufacturer Roche.
Evrysdi from ROCHE gets EC nod as home treatment for spinal muscular atrophy expresspharma
March 31, 2021
Roche announced that the European Commission (EC) has approved Evrysdi (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients two months of age and older, with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to ...
Roche ends tominersen study in manifest Huntington’s disease pharmatimes
March 24, 2021
Swiss pharma company Roche has announced that it will discontinue dosing in a Phase III study evaluating its investigational candidate tominersen in manifest Huntington’s disease.
Roche’s antibody cocktail lowers hospitalisation by 70% in Covid-19 patients pharmaceutical-technology
March 24, 2021
Roche has reported that the Phase III REGN-COV 2067 trial of investigational antibody cocktail of casirivimab and imdevimab met its primary endpoint of reducing the risk of hospitalisation or death in treating high-risk, non-hospitalised Covid-19 ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page